CM
ABCL icon

Caption Management’s AbCellera Biologics ABCL Stock Holding History

Caption Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Hold
0
– – – 1612
2025
Q2 		– Hold
0
– – – 1386
2023
Q1 		– Sell
-88,332
Closed -$895K – 1036
2022
Q4 		$895K Buy
88,332
+83,198
+1,621% +$961K 0.15% 782
2022
Q3 		$51K Buy
+5,134
New +$56.3K 0.01% 1383
2022
Q2 		– Hold
0
– – – 1394
2022
Q1 		– Sell
-70,700
Closed -$669K – 1406
2021
Q4 		$1.01M Buy
70,700
+63,700
+910% +$967K 0.06% 1045
2021
Q3 		$140K Buy
7,000
+6,900
+6,900% +$122K 0.01% 1385
2021
Q2 		$2K Buy
+100
New +$2.76K ﹤0.01% 1245

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return